Virax Biolabs Group Limited (VRAX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.53M |
| Enterprise Value | -321,232 |
| P/E Ratio | -0.13 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 225.24 |
| Price/Book Ratio | 0.14 |
| Enterprise/Revenue | -714.97 |
| Enterprise/EBITDA | 0.39 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -1,890.02 |
| Operating Margin | -1,965.67 |
| Return On Assets | -0.99 |
| Return On Equity | -1.03 |
| Revenue | 6,331 |
| Revenue/Share | 0 |
| Gross Profit | -53,067 |
| EBITDA | -5.8M |
| Net Income | -6.06M |
| Diluted EPS | -1.95 |
| Total Cash | 3.35M |
| Total Cash/Share | 0.7 |
| Total Debt | 537,993 |
| Total Debt/Equity | 0.1 |
| Current Ratio | 11.35 |
| Book Value Per Share | 1.07 |
| 52-Week Change | -79.62 |
| 52-Week High | 1.14 |
| 52-Week Low | 0.1 |
| Moving Average 50 Days | 0.18 |
| Moving Average 200 Days | 0.34 |
| Average Volume | 31.18M |
| Shares Outstanding | 4.34M |
| % Held by Institutions | 0.73 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | December 18, 2023 |